Amerisourcebergen Corp
LSE:0HF3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (0.2), the stock would be worth $258.41 (17% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.2 | $310.53 |
0%
|
| 3-Year Average | 0.2 | $258.41 |
-17%
|
| 5-Year Average | 0.2 | $233.98 |
-25%
|
| Industry Average | 2.1 | $3 165.33 |
+919%
|
| Country Average | 3 | $4 651.62 |
+1 398%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
$76.8B
|
/ |
Jan 2026
$325.8B
|
= |
|
|
$76.8B
|
/ |
Sep 2026
$349.9B
|
= |
|
|
$76.8B
|
/ |
Sep 2027
$373.5B
|
= |
|
|
$76.8B
|
/ |
Sep 2028
$400B
|
= |
|
|
$76.8B
|
/ |
Sep 2029
$426.5B
|
= |
|
|
$76.8B
|
/ |
Sep 2030
$454.9B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.4B USD | 0.2 | 37.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
101.9B USD | 0.3 | 23.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.3B USD | 0.2 | 37.4 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
47.8B USD | 0.2 | 29.1 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.9B AUD | 2.9 | 34.6 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
61.9B CNY | 0.3 | 10.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 0.9 | 22.3 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
60B CNY | 1.7 | 21.2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.8 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.7B HKD | 0 | 7.2 | |
| DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 0.3 | -5.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 3 |
| 70th Percentile | 5.3 |
| Max | 4 613 320.1 |
Other Multiples
Amerisourcebergen Corp
Glance View
AmerisourceBergen Corp., a titan in the realm of pharmaceutical services, orchestrates the flow of medications across a vast and intricate network. Rooted in Chesterbrook, Pennsylvania, the company has cemented its place as a critical link in the healthcare supply chain. Serving as a bridge between pharmaceutical manufacturers and a wide array of healthcare providers like hospitals, clinics, and pharmacies, AmerisourceBergen leverages its expansive distribution infrastructure to ensure that medications and health products reach their destinations efficiently and reliably. The company's operations are bolstered by its strategic partnerships and collaboration with a plethora of healthcare entities, enabling it to integrate seamlessly into the delivery systems that support patient care. At its core, AmerisourceBergen turns the complexity of healthcare logistics into a streamlined process, generating revenue primarily through the distribution of pharmaceuticals. It purchases medications from manufacturers, sells them at a markup to healthcare providers, and in doing so, balances a robust supply chain fueled by efficiency and scale. But the story doesn't end at distribution; the company has expanded its reach through value-added services such as consulting, data analytics, and patient support services that further solidify its role in the healthcare ecosystem. Whether navigating regulatory environments or advising on patient care strategies, AmerisourceBergen positions itself as not just a distributor, but a partner in health. Through this dual approach of distribution and strategic services, the company ensures it remains vital to both manufacturers and healthcare providers, creating a sustainable business model that capitalizes on both volume and innovation.